Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
20/07/201122:21Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201122:21Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201121:05Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201117:39Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201117:16Business WireHarwood Feffer LLP Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201115:37Business WireKendall Law Group Investigates Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201115:37Business WireFaruqi & Faruqi, LLP Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201113:01Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:52Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:49Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:48Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:47Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201112:00Business WireAMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost SynergiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/07/201121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/07/201122:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/06/201121:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/06/201114:30ZacksLabel Expansion for CELG's Istodax - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201122:29Business WireData Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201114:00MarketwiredResearch Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for GrowthNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201111:50GlobeNewswire Inc.Allos Therapeutics is MicroStockProfit.com's Biopharm Feature StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201107:30Business WireData Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/06/201107:30Business WireCOMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH